Edwards Lifesciences
EW
NYSE
IPO2000
about EW
Edwards Lifesciences is a global leader in developing and marketing innovative medical devices, particularly focused on cardiovascular care, including advanced heart valve technologies and minimally invasive solutions to improve patient outcomes.
| type | open | high | low |
market cap |
volume |
|---|---|---|---|---|---|
| stock | $84.12 | $84.50 | $83.04 | $48.9B | 1.86M |
| eps |
price to earnings |
price to sales |
operating margin |
profit margin |
yield |
| +$0.50 | 12.22 | 31.33 | 19.77% | 18.69% | 0% |